----

----

|     Colorado                                    |   | 84-1509950                        |
|---------------------------------------------------------------------|--------|-----------------------------------|
| (State or other jurisdictionof incorporation or organization)  |   | (IRS Employer Identification No.) |

----

| PART I.    FINANCIAL INFORMATION                                                                                   |   |
|----------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                                                                                                                   |   |
| Item 1.       Consolidated Financial Statements                                                          | 3      |
|                                                                                                                                   |   |
| Consolidated Balance Sheet                                                                                                             | 3      |
|                                                                                                                                   |   |
| Consolidated Statements of Operations,                                                                                                 | 5      |
|                                                                                                                                   |   |
| Consolidated Statements of Cash Flows                                                                                                  | 6      |
|                                                                                                                                   |   |
| Consolidated Statements of Comprehensive Loss                                                                                          | 7      |
|                                                                                                                                   |   |
| Consolidated Statement of Stockholders’ (Deficit)                                                                                | 8      |
|                                                                                                                                   |   |
| Notes to Unaudited Consolidated Financial Statements                                                                                   | 9      |
|                                                                                                                                   |   |
| Item 2.       Management's Discussion and Analysis of Financial Condition and Results of Operations | 13     |
|                                                                                                                                   |   |
| Item 3.       Quantitative and Qualitative Disclosures About Market Risk                            | 18     |
|                                                                                                                                   |   |
| Item 4.       Controls and Procedures                                                               | 18     |
|                                                                                                                                   |   |
| Part II. OTHER INFORMATION                                                                                                             |   |
|                                                                                                                                   |   |
| Item 1        Legal Proceedings                                                                | 19     |
|                                                                                                                                   |   |
| Item 1A.    Risk Factors                                                                                                | 19     |
|                                                                                                                                   |   |
| Item 2.       Unregistered Sales of Equity Securities and Use of Proceeds                           | 19     |
|                                                                                                                                   |   |
| Item 3.       Defaults upon Senior Securities                                                       | 19     |
|                                                                                                                                   |   |
| Item 4.       (Removed and Reserved)                                                                | 19     |
|                                                                                                                                   |   |
| Item 5.       Other Information                                                                          | 19     |
|                                                                                                                                   |   |
| Item 6.       Exhibits                                                                              | 19     |
|                                                                                                                                   |   |
| SIGNATURES                                                                                                                             | 20     |
|                                                                                                                                   |   |

----

----

|              |   | June 30,2011 |     |   | September 30,2010 |   |
|--------------------------------------------------------------------------|--------|--------------|----------|--------|-------------------|--------|
|                                                                     |   | (Unaudited)  |     |   | (Audited)         |   |
| Assets                                                                   |   |         |     |   |              |   |
| Current Assets                                                           |   |         |     |   |              |   |
| Cash and cash equivalents                                                |   | $            | 52,193   |   |              | $      | 26,716 |   |
| Accounts receivable                                                      |   |         | 16,395   |   |              |   | 12,809 |   |
| Inventories                                                              |   |         | 360,217  |   |              |   | 224,223 |   |
| Prepaid expenses                                                         |   |         | 39,212   |   |              |   | 20,200 |   |
|                                                                     |   |         |     |   |              |   |   |   |
| Total Current Assets                                                     |   |         | 468,017  |   |              |   | 283,948 |   |
|                                                                     |   |         |     |   |              |   |   |   |
|                                                                     |   |         |     |   |              |   |   |   |
| Long Term Investment                                                     |   |         |     |   |              |   |   |   |
| Investment in MIT China Joint Venture                                    |   |         | 266,632  |   |              |   |      348,434 |   |
|                                                                     |   |         |     |   |              |   |   |   |
| Property and Equipment                                                   |   |         |     |   |              |   |   |   |
| Tooling and machinery                                                    |   |         | 420,065  |   |              |   | 301,995 |   |
| Furniture and office equipment                                           |   |         | 151,187  |   |              |   | 141,600 |   |
| Leasehold improvements                                                   |   |         | 31,104   |   |              |   | 29,132 |   |
|                                                                     |   |         | 602,356  |   |              |   | 472,727 |   |
|                                                                     |   |         |     |   |              |   |   |   |
| Less accumulated depreciation                                            |   |         | (485,051 | )      |              |   | (451,779 | ) |
|                                                                     |   |         | 117,306  |   |              |   | 20,948 |   |
| Other Assets                                                             |   |         |     |   |              |   |   |   |
| Patents (net of accumulated amortization of $3,986 and $7,922)           |   |         | 25,998   |   |              |   | 14,834 |   |
|      Total assets                               |   | $            | 877,954  |   |              | $      | 668,164 |   |

----

| CONSOLIDATED BALANCE SHEET |
|----------------------------|

|                                                                                                                                 |   | June 30 2011 |                                                               |   | September 30 2010 |    |
|--------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------|--------------------------------------------------------------------|--------|------------------------|---------|
|                                                                                                                                 |   | (Unaudited)       |                                                               |   | (Audited)              |    |
| Liabilities and Stockholders' Equity (Deficit)                                                                                       |   |              |                                                               |   |                   |    |
| Current Liabilities                                                                                                                  |   |              |                                                               |   |                   |    |
|         Bank loan                                                                                 |   |  $           | 41,473                                                             |   |                   |  $ | - |   |
|         Deferred income                                                                           |   |              | 1,190,101                                                          |   |                   |    | 1,078,009 |   |
|         Accounts payable and accrued expenses                                                     |   |              | 110,037                                                            |   |                   |    | 312,303 |   |
|         Amounts due to related parties                                                            |   |              | 152,576                                                            |   |                   |    | 178,767 |   |
|         Current portion of long-term debts                                                   |   |              | 16,412                                                             |   |                   |    |   |   |
|                                                                                                                                 |   |              | 1, 510,599                                                         |   |                   |    | 1, 569,079 |   |
|  Long-Term Debts                                                                                                                |   |              |           65,648 |   |                   |    |   |   |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
| Total Liabilities                                                                                                                    |   |              | 1, 576,247                                                         |   |                   |    | 1, 569,079 |   |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
| Stockholders' Equity (Deficit)                                                                                                       |   |              |                                                               |   |                   |    |   |   |
| Preferred stock, $.0001 par value; 3,000,000 shares authorized; None issued and outstanding as of December 31, 2007                  |   |              |                                                               |   |                   |    |   |   |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
| Common stock, $.0001 par value; 100,000,000 shares authorized; 71,478,627 and 66,260,295 shares issued and Outstanding, respectively |   |              | 7,118                                                              |   |                   |    | 6,626 |   |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
| Additional paid-in capital                                                                                                           |   |              | 12,454,085                                                         |   |                   |    | 11,931,996 |   |
| Deficit                                                                                                                              |   |              | (12,754,057                                                        | )      |                   |    | (12,418,732 | ) |
| Other comprehensive income (loss)                                                                                                    |   |              | (405,440                                                           | )      |                   |    | (420,805 | ) |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
| Total Stockholders' Equity (Deficit)                                                                                                 |   |              | (698,294                                                           | )      |                   |    | (900,915 | ) |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |
| Total Liabilities and Stockholders' Equity (Deficit)                                                                                 |   | $                 | 877,953                                                            |   |                   | $       | 668,164 |   |
|                                                                                                                                 |   |              |                                                               |   |                   |    |   |   |

----

|                                                                    |   | Three-Months PeriodEnded June 30, |       |   | Nine-Months Period Ended June 30, |   |
|-------------------------------------------------------------------------|--------|-----------------------------------|------------|--------|----------------------------------------|--------|
|                                                                    |   | 2011(Unaudited)                   |       |   | 2010(Unaudited)                        |   |   | 2011(Unaudited) |   |   | 2010(Unaudited) |   |
| Sales                                                                   |   | $                                 | 89,248     |   |                                   | $      | 161,773 |   |   | $ | 290,503 |   |   | $ | 514,893 |   |
| Cost of sales                                                           |   |                              | (33,909    | )      |                                   |   | (65,392 | ) |   |   | (99,915 | ) |   |   | (163,971 | ) |
| Gross profit (loss)                                                     |   |                              | 55,339     |   |                                   |   | 96,381 |   |   |   | 190,588 |   |   |   | 350,922 |   |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Research and development costs                                          |   |                              | -          |   |                                   |   | (65,194 | ) |   |   | - |   |   |   | (141,678 | ) |
| Selling, general, and administrative expenses                           |   |                              | (433,588   | )      |                                   |   | (100,257 | ) |   |   | (631,234 | ) |   |   | (897,458 | ) |
|                                                                    |   |                              | (433,588   | )      |                                   |   | (165,451 | ) |   |   | (631,234 | ) |   |   | (1,039,136 | ) |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
|  Loss from operations                                              |   |                              | (378,249   | )      |                                   |   | (69,070 | ) |   |   | (440,646 | ) |   |   | (688,214 | ) |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Other Income (Expense)Equity earnings (loss) on MIT China Joint Venture |   |                              | (60,968)   |   |                                   |   | (18,814) |   |   |   | (81,802 | ) |   |   | (68,891 | ) |
| Interest income/loss                                                    |   |                              | -          |   |                                   |   | - |   |   |   | - |   |   |   | - |   |
| Interest expense                                                        |   |                              | (24,647    | )      |                                   |   | (1,622 | ) |   |   | (31,867 | ) |   |   | (8,098 | ) |
|                                                                    |   |                              | (85,615    | )      |                                   |   | (20,436 | ) |   |   | (113,669 | ) |   |   | (76,989 | ) |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Net Loss                                                                |   | $                                 | (463,864   | )      |                                   | $      | (89,506 | ) |   | $ | (554,315 | ) |   | $ | (765,203 | ) |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Basic (loss) per share                                                  |   | $                                 | (0.003     | )      |                                   | $      | (0.001 | ) |   | $ | (0.004 | ) |   | $ | (0.01 | ) |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |
| Basic weighted average shares outstanding                               |   |                              | 71,478,627 |   |                                   |   | 62,297,795 |   |   |   | 71,478,627 |   |   |   | 62,297,795 |   |
|                                                                    |   |                              |       |   |                                   |   |   |   |   |   |   |   |   |   |   |   |

----

|                                                                                        |   | Nine-Month Period Ended |     |
|---------------------------------------------------------------------------------------------|--------|-------------------------|----------|
|                                                                                        |   | June 30,                |     |   | June 30, |   |
|                                                                                        |   | 2011                    |     |   | 2010 |   |
| Cash flows from operating activities:                                                       |   |                    |     |   |   |   |
| Net loss                                                                                    |   | $                       | (554,315 | ) |   | $ | (765,203 | ) |
| Adjustments to reconcile net loss to net cash                                               |   |                    |     |   |   |   |   |   |
|   provided by (used in) operating activities:                                     |   |                    | 218,991  |   |   |   | - |   |
|     Warrant expense                                                     |   |                    |     |   |   |   |   |   |
|     Equity loss from MIT China Joint Venture                            |   |                    | 81,802   |   |   |   | 68,891 |   |
|     Depreciation and amortization expense                               |   |                    | 27,232   |   |   |   | 16,456 |   |
|                                                                                        |   |                    |     |   |   |   |   |   |
|     Common stock issued for services                                    |   |                    | 31,000   |   |   |   | 333,400 |   |
|     Related party payables settle by common stock                       |   |                    | -        |   |   |   | - |   |
|     Capitalization of related party debts                               |   |                    |     |   |   |   | 3,403,981 |   |
|                                                                                        |   |                    |     |   |   |   |   |   |
| Changes in:                                                                                 |   |                    |     |   |   |   |   |   |
|     Accounts receivable                                                 |   |                    | (3,586   | ) |   |   | (6,535 | ) |
|                                                                                        |   |                    |     |   |   |   |   |   |
|     Inventories                                                         |   |                    | (135,994 | ) |   |   | (16,529 | ) |
|     Prepaid expenses                                                    |   |                    | (19,013  | ) |   |   | (952 | ) |
|     Accounts payable and accrued liabilities                            |   |                    | (202,266 | ) |   |   | (223,971 | ) |
|                                                                                        |   |                    |     |   |   |   |   |   |
|     Deferred income                                                     |   |                    | 112,092  |   |   |   | (120,528 | ) |
|          Net cash used by operating activities |   |                    | (444,057 | ) |   |   | 2,689,010 |   |
|                                                                                        |   |                    |     |   |   |   |   |   |
| Cash flows from investing activities:                                                       |   |                    |     |   |   |   |   |   |
|     Acquisition of patents                                              |   |                    | (10,579  | ) |   |   | (10,169 | ) |
|     Investment in MIT China joint venture                               |   |                    | -        |   |   |   | (10,437 | ) |
|     Tooling and machinery                                               |   |                    | (97,625  | ) |   |   | - |   |
|         Net cash used by investing activities       |   |                    | (108,204 | ) |   |   | (20,606 | ) |
|                                                                                        |   |                    |     |   |   |   |   |   |
| Cash flows from financing activities:                                                       |   |                    |     |   |   |   |   |   |
|    Bank loans                                                                |   |                    | 123,533  |   |   |   | - |   |
|    Proceeds from issuance of stock, net                                      |   |                    | 491,581  |   |   |   | 100,000 |   |
|    Increase in amounts due to related parties                                |   |                    | (26,191  | ) |   |   | (3,156,564 | ) |
|    Issuance of notes payable                                                 |   |                    | -        |   |   |   | - |   |
|    Repayment on notes payable                                                |   |                    | -        |   |   |   | (5,406 | ) |
|         Net cash provided from financing activities |   |                    | 588,923  |   |   |   | (3,061,970 | ) |
|                                                                                        |   |                    |     |   |   |   |   |   |
| Effect of exchange rates                                                                    |   |                    | (11,185  | ) |   |   | 425,997 |   |
|                                                                                        |   |                    |     |   |   |   |   |   |
|                                                                                        |   |                    |     |   |   |   |   |   |
| Increase (decrease) in cash                                                                 |   |                    | 25,477   |   |   |   | 32,431 |   |
| Cash, beginning of period                                                                   |   |                    | 26,716   |   |   |   | 77,461 |   |
| Cash, end of period                                                                         |   | $                       | 52,193   |   |   | $ | 109,892 |   |
| Supplemental disclosure of cash flow information:                                           |   |                    |     |   |   |   |   |   |
|     Cash paid for interest                                              |   | $                       | 31,867   |   |   | $ | 8,099 |   |
|     Cash paid for federal income taxes                                  |   | $                       | -        |   |   | $ | - |   |
| Supplemental disclosure of non-cash transactions                                            |   |                    |     |   |   |   |   |   |
|    Common stock issued for debt reductions                                   |   | $                       | -        |   |   | $ | - |   |

----

| CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS |
|-----------------------------------------------|

|                                                                 |   | Nine Months endingJune 30,2011 |     |   | Nine Months endingJune 30,2010 |   |
|----------------------------------------------------------------------|--------|--------------------------------|----------|--------|--------------------------------|--------|
| Net loss                                                             |   | $                              | (554,315 | )      |                           | $      | (765,203 | ) |
| Other comprehensive income (loss)                                    |   |                           |     |   |                           |   |   |   |
| Foreign currency translation adjustment                              |   |                           | (15,365) |   |                           |   | 426,501 |   |
|                                                                 |   |                           |     |   |                           |   |   |   |
|        Net comprehensive income (loss) |   | $                              | (569,680 | )      |                           | $      | (338,702 | ) |

----

| CONSOLIDATED STATEMENT OF STOCKHOLDERS’ (DEFICIT) |
|---------------------------------------------------------|

|                                                              |   | Common Stock |       |   | Additional Paid in |   |
|-------------------------------------------------------------------|--------|--------------|------------|--------|--------------------|--------|
|                                                              |   | Shares       |       |   | Amount             |   |   | Capital |   |   | Deficit |   |
|                                                              |   |         |       |   |               |   |   |   |   |   |   |   |
| Balance – September 30, 2010                                |   |         | 66,260,295 |   |               | $      | 6,626 |   |   | $ | 11,931,996 |   |   | $ | (12,418,733 | ) |
|                                                              |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Shares issued for debts                                           |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | - |   |
| Shares issued for services                                        |   |         | 10,000     |   |               |   | 1 |   |   |   | 999 |   |   |   | - |   |
| Shares issued for additional capital                              |   |         | 1,760,000  |   |               |   | 147 |   |   |   | 176,601 |   |   |   | - |   |
|                                                              |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Net loss for the period ended December 31, 2010                   |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | (71,587 | ) |
| Balance – December 31, 2010                                 |   |         | 68,030,295 |   |               | $      | 6,774 |   |   | $ | 12,109,596 |   |   | $ | (12,490,320 | ) |
|                                                              |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Net loss for the period ended March 31, 2011                      |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | (18,864) |   |
| Balance – March 31, 2011                                    |   |         | 68,030,295 |   |               | $      | 6,774 |   |   | $ | 12,109,596 |   |   | $ | (12,509,184) |   |
|                                                              |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Shares issued for debts                                           |   |         | 365,000    |   |               |   | 36 |   |   |   | 36,464 |   |   |   | - |   |
| Shares issued for services                                        |   |         | 300,000    |   |               |   | 30 |   |   |   | 29,970 |   |   |   | - |   |
| Shares issued for additional capital                              |   |         | 2,783,332  |   |               |   | 278 |   |   |   | 278,055 |   |   |   | - |   |
| Warrant expense                                                   |   |         |       |   |               |   |   |   |   |   | 218,991 |   |   |   |   |   |
|                                                              |   |         |       |   |               |   |   |   |   |   |   |   |   |   |   |   |
| Net loss for the period ended  June  30, 2011 |   |         | -          |   |               |   | - |   |   |   | - |   |   |   | (463,864) |   |
| Balance – June 30, 2011                                     |   |         | 71,478,627 |   |               |   | 7,118 |   |   |   | 12,673,076 |   |   |   | (13,217,921 | ) |

----

|            |   | June 30,2011 |    |   | September 30,2010 |   |
|-----------------|--------|--------------|---------|--------|-------------------|--------|
| Raw materials   |   | $            | 221,710 |   |              | $      | 166,611 |   |
| Work in process |   |         | 76,250  |   |              |   | 47,259 |   |
| Finished goods  |   |         | 62,257  |   |              |   | 10,353 |   |
| Total           |   | $            | 360,217 |   |              | $      | 224,223 |   |

----

|    |   | GrossIntangibleAssets |   |   | Accumulated Amortization |   |   | Net IntangibleAssets |   | WeightedAverageLife(Years) |
|---------|--------|-----------------------|--------|--------|--------------------------|--------|--------|---------------------------|--------|----------------------------|
| Patents |   | $                     | 33,920 |   |                     | $      | 7,922  |                      |   | $                          | 25,998 |   | 8.5 through 16 |

|                            |   | June 30,2011 |                      |   | September 30,2010 |   |
|---------------------------------|--------|--------------|---------------------------|--------|-------------------|--------|
| Payable to 2849-674 Canada Inc  |   | $            | 72,576                    |   |              | $      | 67,974 |   |
| Payable to Pascal D'Onofrio     |   |         |     - |   |              |   |          30,793 |   |
| Payable to 9211-0766 Quebec Inc |   |         | 80,000                    |   |              |   |          80,000 |   |
|                            |   |         |                      |   |              |   |   |   |
|                            |   | $            | 152,576                   |   |              | $      | 178,767 |   |

|                                                                                               |   | June 30,2011 |     |   | September 30,2010 |   |
|----------------------------------------------------------------------------------------------------|--------|--------------|----------|--------|-------------------|--------|
| Note payable to a bank, bearing interest at prime plus 3%, secured by equipment, due June 21, 2016 |   | $            | 82,061   |   |              | $      | 0 |   |
|                                                                                               |   |         |     |   |              |   |   |   |
| Current portion of long-term debt                                                                  |   |         | (16,412) |   |              |   | 0 |   |
|                                                                                               |   |         |     |   |              |   |   |   |
| Long-term debt                                                                                     |   | $            | 65 648   |   |              | $      | - |   |

----

----

----

----

----

----

----

----

----

----

|                                                | Medical International Technology, Inc. |                                                                                                                                               |
|-----------------------------------------------------|----------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                |                                   |                                                                                                                                               |   |
| Date: August 22, 2011      | By:                                    | /s/ Karim Menassa                                                                                                                        |   |
|                                                |                                   | Karim Menassa                                                                                                                                      |   |
|                                                |                                   | President and Principal Executive Officer                                                                                                          |   |
|                                                |                                   | Interim Secretary and Chief Financial Officer(Duly Authorized Officer, Principal Executive Officer and Principal Financial and Accounting Officer) |   |

----